Nada Lallous
Nada Lallous
Assistant Professor, University of British Columbia
prostatecentre.com üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
N Lallous, SV Volik, S Awrey, E Leblanc, R Tse, J Murillo, K Singh, ...
Genome Biology 17 (10), 2016
1322016
Targeting alternative sites on the androgen receptor to treat castration-resistant prostate cancer
N Lallous, K Dalal, A Cherkasov, PS Rennie
International journal of molecular sciences 14 (6), 12496-12519, 2013
632013
Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancer
RSN Munuganti, MDH Hassona, E Leblanc, K Frewin, K Singh, D Ma, ...
Chemistry & biology 21 (11), 1476-1485, 2014
472014
Structure, functional characterization, and evolution of the dihydroorotase domain of human CAD
A Grande-García, N Lallous, C Díaz-Tejada, S Ramón-Maiques
Structure 22 (2), 185-198, 2014
462014
The PHD finger of human UHRF1 reveals a new subgroup of unmethylated histone H3 tail readers
N Lallous, P Legrand, AG McEwen, S Ramón-Maiques, JP Samama, ...
PloS one 6 (11), e27599, 2011
432011
Moving towards precision urologic oncology: targeting enzalutamide-resistant prostate cancer and mutated forms of the androgen receptor using the novel inhibitor darolutamide …
H Borgmann, N Lallous, D Ozistanbullu, E Beraldi, N Paul, K Dalal, L Fazli, ...
European urology 73 (1), 4-8, 2018
412018
An oncofetal glycosaminoglycan modification provides therapeutic access to cisplatin-resistant bladder cancer
R Seiler, HZ Oo, D Tortora, TM Clausen, CK Wang, G Kumar, MA Pereira, ...
European urology 72 (1), 142-150, 2017
292017
In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α
K Singh, RSN Munuganti, E Leblanc, YL Lin, E Leung, N Lallous, M Butler, ...
Breast Cancer Research 17 (1), 1-17, 2015
222015
Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer
LA Carabet, N Lallous, E Leblanc, F Ban, H Morin, S Lawn, F Ghaidi, ...
European journal of medicinal chemistry 160, 108-119, 2018
212018
Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor–Chromatin Interactions
K Dalal, M Che, NS Que, A Sharma, R Yang, N Lallous, H Borgmann, ...
Molecular cancer therapeutics 16 (10), 2281-2291, 2017
182017
Targeting binding function-3 of the androgen receptor blocks its co-chaperone interactions, nuclear translocation, and activation
N Lallous, E Leblanc, RSN Munuganti, MDH Hassona, N Al Nakouzi, ...
Molecular cancer therapeutics 15 (12), 2936-2945, 2016
172016
Androgen receptor plasticity and its implications for prostate cancer therapy
O Snow, N Lallous, K Singh, N Lack, P Rennie, A Cherkasov
Cancer treatment reviews 81, 101871, 2019
152019
Expression, purification, crystallization and preliminary X-ray diffraction analysis of the aspartate transcarbamoylase domain of human CAD
A Ruiz-Ramos, N Lallous, A Grande-García, S Ramón-Maiques
Acta Crystallographica Section F: Structural Biology and Crystallization …, 2013
142013
Computer-aided discovery of small molecules targeting the RNA splicing activity of hnRNP A1 in castration-resistant prostate cancer
LA Carabet, E Leblanc, N Lallous, H Morin, F Ghaidi, J Lee, PS Rennie, ...
Molecules 24 (4), 763, 2019
132019
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models
L Nappi, AH Aguda, N Al Nakouzi, B Lelj-Garolla, E Beraldi, N Lallous, ...
The Journal of clinical investigation 130 (2), 699-714, 2020
122020
Cheminformatics Modeling of Adverse Drug Responses by Clinically Relevant Mutants of Human Androgen Receptor
AC Naman Paul, Lavinia Arielle Carabet, Nada Lallous, Takeshi Yamazaki ...
Journal of Chemical Information and Modeling, 2016
112016
Androgen receptor-binding sites are highly mutated in prostate cancer
T Morova, DR McNeill, N Lallous, M Gönen, K Dalal, DM Wilson, A Gürsoy, ...
Nature communications 11 (1), 1-10, 2020
92020
Benzothiophenone derivatives targeting mutant forms of estrogen receptor-α in hormone-resistant breast cancers
K Singh, RSN Munuganti, N Lallous, K Dalal, JS Yoon, A Sharma, ...
International journal of molecular sciences 19 (2), 579, 2018
92018
Expression, purification, crystallization and preliminary X-ray diffraction analysis of the dihydroorotase domain of human CAD
N Lallous, A Grande-García, R Molina, S Ramón-Maiques
Acta Crystallographica Section F: Structural Biology and Crystallization …, 2012
92012
Expression, purification, crystallization and preliminary crystallographic study of the SRA domain of the human UHRF1 protein
B Delagoutte, N Lallous, C Birck, P Oudet, JP Samama
Acta Crystallographica Section F: Structural Biology and Crystallization …, 2008
92008
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20